With respect to the effect of aspirin on cancer cell stemness properties, we found that the immunocytochemical staining of SOX2 and OCT4 stemness markers decreases in the cisplatin/aspirin-treated groups versus DMSO controls (Fig. 2o, p). Here, POU5F1 is linked to cancer.